BioVie Inc
BIVI6.040USD
+0.010+0.17%
交易中 （美东）报价延迟15分钟
111.84M总市值
亏损市盈率 TTM
关于 BioVie Inc 公司
BioVie Inc. 是一家临床阶段公司，致力于开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病。在神经退行性疾病方面，该公司的候选药物 bezisterim (NE3107) 可抑制细胞外信号调节激酶和转录因子核因子 kB 的炎症激活，以及相关的神经炎症和胰岛素抵抗，但不能抑制细胞外单调节激酶 (ERK) 和活化 B 细胞的核因子 kappa 轻链增强子 (NFkB) 稳态功能（胰岛素信号传导和神经元生长和存活）。炎症和胰岛素抵抗都是阿尔茨海默病 (AD) 和帕金森病 (PD) 的驱动因素。在肝病方面，其孤儿药候选药物 BIV201（持续输注特利加压素）正在进行 BIV201 的 3 期临床试验，用于减少肝硬化和腹水患者的进一步失代偿。
公司简介
公司代码BIVI
公司名称BioVie Inc
上市日期Jan 14, 2014
CEOMr. Viet Cuong Do
员工数量14
证券类型Ordinary Share
年结日Jan 14
公司地址680 W Nye Lane
城市CARSON CITY
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编89703
电话17758883162
网址https://www.bioviepharma.com/
公司代码BIVI
上市日期Jan 14, 2014
CEOMr. Viet Cuong Do
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.09K
+902.75%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
841.00
+901.19%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
689.00
+898.55%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
+890.48%
Mr. Richard J. Berman
Mr. Richard J. Berman
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sigmund (Sig) Rogich
Mr. Sigmund (Sig) Rogich
Independent Director
Independent Director
--
--
Ms. Amy Chappell, M.D.
Ms. Amy Chappell, M.D.
Director
Director
--
--
Mr. Kameel D. Farag
Mr. Kameel D. Farag
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.09K
+902.75%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
841.00
+901.19%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
689.00
+898.55%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
+890.48%
Mr. Richard J. Berman
Mr. Richard J. Berman
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月26日 周六
更新时间: 7月26日 周六
持股股东
股东类型
持股股东
持股股东
占比
Acuitas Group Holdings LLC
12.47%
The Vanguard Group, Inc.
2.89%
Geode Capital Management, L.L.C.
0.74%
Do Cuong Viet
0.31%
GWM Advisors LLC
0.29%
Other
83.29%
持股股东
持股股东
占比
Acuitas Group Holdings LLC
12.47%
The Vanguard Group, Inc.
2.89%
Geode Capital Management, L.L.C.
0.74%
Do Cuong Viet
0.31%
GWM Advisors LLC
0.29%
Other
83.29%
股东类型
持股股东
占比
Corporation
12.47%
Investment Advisor
4.51%
Investment Advisor/Hedge Fund
0.93%
Individual Investor
0.84%
Hedge Fund
0.15%
Research Firm
0.03%
Other
81.07%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
150
132.06K
7.11%
-381.94K
2025Q1
160
3.53M
36.23%
-1.67M
2024Q4
161
3.27M
17.78%
-55.97K
2024Q3
156
2.82M
17.58%
-327.33K
2024Q2
149
2.93M
48.15%
-286.77K
2024Q1
142
3.11M
175.46%
+382.36K
2023Q4
137
2.62M
70.26%
-64.72K
2023Q3
129
2.61M
70.37%
-91.05K
2023Q2
117
2.63M
74.62%
+3.43K
2023Q1
89
2.59M
74.46%
+69.39K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Acuitas Group Holdings LLC
231.63K
12.47%
-37.00
-0.02%
Jun 25, 2025
The Vanguard Group, Inc.
53.66K
2.89%
+44.64K
+494.42%
Mar 31, 2025
Geode Capital Management, L.L.C.
13.80K
0.74%
+1.46K
+11.84%
Mar 31, 2025
Do Cuong Viet
5.70K
0.31%
+864.00
+17.85%
May 30, 2025
GWM Advisors LLC
5.41K
0.29%
+4.00K
+283.69%
Mar 31, 2025
Swisspartners Investment Network AG
5.33K
0.29%
+2.33K
+77.60%
Jun 30, 2024
UBS Financial Services, Inc.
4.98K
0.27%
+148.00
+3.06%
Mar 31, 2025
Berman (Richard Jay)
4.06K
0.22%
+3.42K
+531.06%
Nov 20, 2024
Sanders Morris LLC
4.00K
0.22%
--
--
Mar 31, 2025
Rogich Sigmund A
2.13K
0.11%
-1.56K
-42.24%
May 30, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
占比0%
Proshares Ultra Russell 2000
占比0%
iShares Micro-Cap ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Global X Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
公告日期
类型
比率
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
Aug 01, 2024
Merger
10<1
